Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir,
identifying one or more dosing regimens of atazanavir/ritonavir/tenofovir when dosed with
famotidine results in atazanavir exposures similar to those when
atazanavir/ritonavir/tenofovir 300/100/300 mg is dosed without famotidine in healthy
subjects.